XML 49 R34.htm IDEA: XBRL DOCUMENT
v3.22.4

Net Income per share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share, Basic and Diluted | A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):
|  | Twelve Months Ended December 31,
|  | 2022 |  | 2021 |  | 2020
Numerator: |  |  |  |  |  |
Net income |  | $ | 202,129 |  |  | $ | 402,710 |  |  | $ | 129,085 |
Denominator: |  |  |  |  |  |
Weighted average common shares outstanding for basic net income per share |  | 136,844 |  |  | 140,646 |  |  | 136,206 |
Dilutive potential common stock outstanding: |  |  |  |  |  |
Stock Options |  | 2,265 |  |  | 2,737 |  |  | 2,317 |
RSAs, RSUs, PSUs and ESPP |  | 422 |  |  | 555 |  |  | 627 |
Convertible Notes |  | 1,077 |  |  | 2,858 |  |  | 2,313 |
Weighted average common shares outstanding for diluted net income per share |  | 140,608 |  |  | 146,796 |  |  | 141,463 |
Net income per share: |  |  |  |  |  |
Basic |  | $ | 1.48 |  |  | $ | 2.86 |  |  | $ | 0.95 |
Diluted |  | $ | 1.44 |  |  | $ | 2.74 |  |  | $ | 0.91 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Shares which have been excluded from the calculation of diluted net income per common share because their effect was anti-dilutive, include the following (shares in millions):
|  | Twelve Months Ended December 31,
|  | 2022 |  | 2021 |  | 2020
Anti-dilutive securities (1) |  | 20.7 |  |  | 13.8 |  |  | 18.6 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration